Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Am J Transplant ; 13(5): 1305-16, 2013 May.
Artículo en Inglés | MEDLINE | ID: mdl-23489474

RESUMEN

Posttransplant patients are at risk of developing a potentially life-threatening posttransplantation lymphoproliferative disorder (PTLD), most often of diffuse large B cell lymphoma (DLBCL) morphology and associated with Epstein-Barr Virus (EBV) infection. The aim of this study was to characterize the clinicopathological and molecular-genetic characteristics of posttransplant DLBCL and to elucidate whether EBV(+) and EBV(-) posttransplant DLBCL are biologically different. We performed gene expression profiling studies on 48 DLBCL of which 33 arose posttransplantation (PT-DLBCL; 72% EBV+) and 15 in immunocompetent hosts (IC-DLBCL; none EBV+). Unsupervised hierarchical analysis showed clustering of samples related to EBV-status rather than immune status. Except for decreased T cell signaling these cases were inseparable from EBV(-) IC-DLBCL. In contrast, a viral response signature clearly segregated EBV(+) PT-DLBCL from EBV(-) PT-DLBCL and IC-DLBCL cases that were intermixed. The broad EBV latency profile (LMP1+/EBNA2+) was expressed in 59% of EBV(+) PT-DLBCL and associated with a more elaborate inflammatory response compared to intermediate latency (LMP1+/EBNA2-). Inference analysis revealed a role for innate and tolerogenic immune responses (including VSIG4 and IDO1) in EBV(+) PT-DLBCL. In conclusion we can state that the EBV signature is the most determining factor in the pathogenesis of EBV(+) PT-DLBCL.


Asunto(s)
Infecciones por Virus de Epstein-Barr/complicaciones , Perfilación de la Expresión Génica/métodos , Regulación Neoplásica de la Expresión Génica , Herpesvirus Humano 4/genética , Trastornos Linfoproliferativos/genética , Trasplante de Órganos , Proteínas Virales/biosíntesis , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Infecciones por Virus de Epstein-Barr/genética , Infecciones por Virus de Epstein-Barr/virología , Femenino , Estudios de Seguimiento , Humanos , Hibridación in Situ , Trastornos Linfoproliferativos/complicaciones , Trastornos Linfoproliferativos/metabolismo , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Proteínas Virales/genética , Latencia del Virus , Adulto Joven
2.
Proc Natl Acad Sci U S A ; 105(28): 9775-80, 2008 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-18626010

RESUMEN

Regulated intramembrane proteolysis by gamma-secretase cleaves proteins in their transmembrane domain and is involved in important signaling pathways. At least four different gamma-secretase complexes have been identified, but little is known about their biological role and specificity. Previous work has demonstrated the involvement of the Aph1A-gamma-secretase complex in Notch signaling, but no specific function could be assigned to Aph1B/C-gamma-secretase. We demonstrate here that the Aph1B/C-gamma-secretase complex is expressed in brain areas relevant to schizophrenia pathogenesis and that Aph1B/C deficiency causes pharmacological and behavioral abnormalities that can be reversed by antipsychotic drugs. At the molecular level we find accumulation of Nrg1 fragments in the brain of Aph1BC(-/-) mice. Our observations gain clinical relevance by the demonstration that a Val-to-Leu mutation in the Nrg1 transmembrane domain, associated with increased risk for schizophrenia, affects gamma-secretase cleavage of Nrg1. This finding suggests that dysregulation of intramembrane proteolysis of Nrg1 could increase risk for schizophrenia and related disorders.


Asunto(s)
Secretasas de la Proteína Precursora del Amiloide/deficiencia , Antipsicóticos/farmacología , Endopeptidasas/deficiencia , Trastornos Neurológicos de la Marcha/etiología , Neurregulina-1/metabolismo , Subunidades de Proteína/deficiencia , Animales , Antipsicóticos/uso terapéutico , Proteínas de la Membrana , Ratones , Ratones Noqueados , Mutación Missense/fisiología , Esquizofrenia/etiología
4.
Proc Natl Acad Sci U S A ; 96(21): 11872-7, 1999 Oct 12.
Artículo en Inglés | MEDLINE | ID: mdl-10518543

RESUMEN

Mutations in the homologous presenilin 1 (PS1) and presenilin 2 (PS2) genes cause the most common and aggressive form of familial Alzheimer's disease. Although PS1 function and dysfunction have been extensively studied, little is known about the function of PS2 in vivo. To delineate the relationships of PS2 and PS1 activities and whether PS2 mutations involve gain or loss of function, we generated PS2 homozygous deficient (-/-) and PS1/PS2 double homozygous deficient mice. In contrast to PS1(-/-) mice, PS2(-/-) mice are viable and fertile and develop only mild pulmonary fibrosis and hemorrhage with age. Absence of PS2 does not detectably alter processing of amyloid precursor protein and has little or no effect on physiologically important apoptotic processes, indicating that Alzheimer's disease-causing mutations in PS2, as in PS1, result in gain of function. Although PS1(+/-) PS2( -/-) mice survive in relatively good health, complete deletion of both PS2 and PS1 genes causes a phenotype closely resembling full Notch-1 deficiency. These results demonstrate in vivo that PS1 and PS2 have partially overlapping functions and that PS1 is essential and PS2 is redundant for normal Notch signaling during mammalian embryological development.


Asunto(s)
Proteínas de la Membrana/genética , Proteínas de la Membrana/fisiología , Precursor de Proteína beta-Amiloide/fisiología , Animales , Apoptosis , Genotipo , Hipocampo/metabolismo , Homocigoto , Pulmón/metabolismo , Proteínas de la Membrana/deficiencia , Proteínas de la Membrana/metabolismo , Ratones , Ratones Noqueados , Modelos Genéticos , Mutagénesis , Fenotipo , Presenilina-1 , Presenilina-2 , Receptores Notch , Factores de Tiempo , Distribución Tisular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA